2019 Wellness Conference
 
Symposium Faculty and Planning Committee
Southern California Permanente Medical Group

Mark Ashley, MD
Lead Clinician Patient Communication

Columbus Batiste, MD, FACC, FSCAI
Cardiology
SCPMG – Riverside

Benjamin Ha, MD
Family Physician
SCPMG – Kern County

Sean Hashmi, MD, MS, FASN
Regional Lead for Nutrition and Weight Management
SCPMG

Barry Kerzin, MD
President
Altruism in Medicine Institute

Ary Kian, MD
Resident Physician
SCPMG

Steven Lawenda, MD
Co-creator of Life 180 (Lifestyle Med group program
focused on plant-based diet) and
Plants for Life (plant-based diet class)
Hypertension lead for Antelope Valley

Vu Thuy Nguyen, MD
Regional Assistant Medical Director, Patient Safety and Perioperative Services
Elected Member of the Board, SCPMG
Departments of Anesthesiology and Internal Medicine
SCPMG – Baldwin Park

Alex Soojung-Kim Pang, PhD
Author of REST and THE DISTRACTION ADDICTION
The Restful Company

Leonard Perlmutter
Founder and Director
The American Meditation Institute

Tait Shanafelt, MD
Jeanie & Stewart Ritchie Professor of Medicine
Chief Wellness Officer, Stanford Medicine
Director, WellMD Center
Associate Dean, Stanford School of Medicine

Linda Shiue, MD, Chef
Director of Culinary Medicine
TPMG - San Francisco

SYMPOSIUM CHAIRPERSON
Dawn Clark, MD
Chief Wellness Officer
Regional Assistant Medical Director
Obstetrics and Gynecology
SCPMG - San Dimas and Baldwin Park

PLANNING COMMITTEE
Roger Benton
Program Manager, Healthy Workforce
SCPMG
Regional Offices

Andy Gallardo, CPT-NASM

Director of Fitness
Healthy Workforce
Regional Offices
SCPMG

Ary Kian
Resident Physician
SCPMG

Helen Kim, MD
Anesthesiology/Pain Management
SCPMG - Riverside

Jenifer Luu, MHA
Sr. Consultant
Physician Wellness
SCPMG Consulting & Implementation

Vu Thuy Nguyen, MD
Anesthesiology, General
SCPMG

Vyacheslav O. Shvartsman, MD
Internal Medicine, General
SCPMG – Palm Springs

Carol O'Neal
Sr. Learning Consultant
Physician Education
Regional Offices
SCPMG


PLANNING COMMITTEE DISCLOSURE STATEMENT
The planning committee members and their partners have nothing to disclose regarding any relationship with a pharmaceutical or industrial concern which might pose a potential, apparent, or real conflict of interest with regard to the planning of this activity.